Blood counts from 11 renal patients before and during 8 weeks of rhEPO therapy
. | Erythrocyte count, × 103/μL . | Blood hemoglobin level, g/L . | Hematocrit level, % . | Thrombocyte count, × 106/μL . | Leukocyte count, × 103/μL . |
|---|---|---|---|---|---|
| Baseline | 3.51 ± 0.13 | 9.6 ± 0.3 | 29.6 ± 1.0 | 247 ±25 | 7.7 ± 1.1 |
| 2 weeks | 3.48 ± 0.08 | 10.3 ± 0.3 | 32.0 ± 1.0 | 273 ± 45 | 6.9 ± 0.9 |
| 4 weeks | 3.56 ± 0.12 | 10.7 ± 0.3 | 32.5 ± 0.9 | 296 ± 28 | 6.8 ± 0.7 |
| 6 weeks | 3.62 ± 0.08 | 10.9 ± 0.3 | 34.0 ± 1.0 | 307 ± 34 | 6.6 ± 0.4 |
| 8 weeks | 3.79 ± 0.11 | 11.1 ± 0.3* | 34.6 ± 1.3* | 311 ± 30 | 7.7 ± 0.6 |
. | Erythrocyte count, × 103/μL . | Blood hemoglobin level, g/L . | Hematocrit level, % . | Thrombocyte count, × 106/μL . | Leukocyte count, × 103/μL . |
|---|---|---|---|---|---|
| Baseline | 3.51 ± 0.13 | 9.6 ± 0.3 | 29.6 ± 1.0 | 247 ±25 | 7.7 ± 1.1 |
| 2 weeks | 3.48 ± 0.08 | 10.3 ± 0.3 | 32.0 ± 1.0 | 273 ± 45 | 6.9 ± 0.9 |
| 4 weeks | 3.56 ± 0.12 | 10.7 ± 0.3 | 32.5 ± 0.9 | 296 ± 28 | 6.8 ± 0.7 |
| 6 weeks | 3.62 ± 0.08 | 10.9 ± 0.3 | 34.0 ± 1.0 | 307 ± 34 | 6.6 ± 0.4 |
| 8 weeks | 3.79 ± 0.11 | 11.1 ± 0.3* | 34.6 ± 1.3* | 311 ± 30 | 7.7 ± 0.6 |
Values are ± SEM.
P < .05, comparison of week 8 versus baseline.